VESALIUS-CV was big in 2025, but studies looking at triglycerides, CRISPR, and oral GLP-1s also made the highlight reel.
The global prime editing and CRISPR market size was US$ 3,194.2 million in 2021. The global prime editing and CRISPR market is forecast to grow to US$ 17,618.4 million by 2030 by registering a ...
Tribune Online on MSN
How we can have mosquitoes around us with little or no malaria — Sabina Eze, researcher, entomologist
Sabina Chioma Eze is a researcher in zoology, medical and forensic entomology. She is an assistant lecturer at the Federal University of Health Sciences, Otukpo (FUHSO), Benue State, and a graduate ...
Zacks Small Cap Research on MSN
DYAI: Layers of commercialization agreements
The new arrangements were all announced in December and include a development and commercialization agreement signed with BRIG BIO, a commercial partnership with Opes Diagnostics and an expansion of ...
Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy ...
Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on what made us select ...
Modalis Therapeutics Corporation (TOKYO: 4883) today announced that its research article titled "Efficient LAMA1 gene activation by epigenome editing as a therapeutic approach for LAMA2-CMD" has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback